Enanta Pharma (ENTA) Gains on FDA Approval for AbbVie's (ABBV) VIEKIRA PAK
Tweet Send to a Friend
Enanta Pharma (NASDAQ: ENTA) is gaining (+15.8%) in pre-open trade Monday after the company announced the FDA has approved AbbVie’s ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
